Q Fever Pneumonia in French Guiana: Prevalence, Risk Factors, and Prognostic Score - Archive ouverte HAL
Article Dans Une Revue Clinical Infectious Diseases Année : 2012

Q Fever Pneumonia in French Guiana: Prevalence, Risk Factors, and Prognostic Score

Q fever pneumonia in French Guiana: prevalence, risk factors, and prognostic score.

Résumé

Community-acquired pneumonia (CAP) is the major manifestation of Q fever, an emerging disease in French Guiana. Consequently, the empirical antibiotherapy used for the treatment of CAP combines doxycycline and the recommended amoxicillin. Our objectives were to estimate the prevalence of Q fever pneumonia and to build a prediction rule to identify patients with Q fever pneumonia for empirical antibiotic guidance.

Dates et versions

hal-01845479 , version 1 (20-07-2018)

Identifiants

Citer

Loïc Epelboin, Cédric Chesnais, Charlotte Boullé, Anne-Sophie Drogoul, Didier Raoult, et al.. Q Fever Pneumonia in French Guiana: Prevalence, Risk Factors, and Prognostic Score. Clinical Infectious Diseases, 2012, 55 (1), pp.67 - 74. ⟨10.1093/cid/cis288⟩. ⟨hal-01845479⟩
179 Consultations
0 Téléchargements

Altmetric

Partager

More